SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Devon Park Associates, L.P. (Last) (First) (Middle) 1400 LIBERTY RIDGE DRIVE, SUITE 103 (Street) WAYNE PA 19087 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol INOTEK PHARMACEUTICALS CORP [ ITEK ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 07/14/2015
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/14/2015		M		9,857	A	$4.342	3,253,566	D(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$4.342	07/14/2015		M			9,857	(2)	08/28/2024	Common Stock	9,857	$0.00	0	I	See Footnote(3)

1. Name and Address of Reporting Person* Devon Park Associates, L.P. (Last) (First) (Middle) 1400 LIBERTY RIDGE DRIVE, SUITE 103 (Street) WAYNE PA 19087 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Devon Park Associates, LLC (Last) (First) (Middle) 1400 LIBERTY RIDGE DRIVE, SUITE 103 (Street) WAYNE PA 19087 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Kantesaria Devang (Last) (First) (Middle) 1400 LIBERTY RIDGE DRIVE, SUITE 103 (Street) WAYNE PA 19087 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. The 9,857 shares of Common Stock were assigned by Dr. Devang Kantesaria to Devon Park Associates, L.P. immediately upon exercise of the underlying options. Dr. Kantesaria, along with Messrs. Marc Ostro and Christopher Moller (collectively, the "Founding Members"), are the founding and managing members of Devon Park Associates, LLC, which is the general partner of Devon Park Associates, L.P. Dr. Kantesaria is contractually obligated to assign the value of these securities to Devon Park Associates, L.P. Each Founding Member further disclaims beneficial ownership of these securities, except to the extent of such Founding Member's pecuniary interest therein, and this report shall not be deemed an admission that the Founding Members are the beneficial owner of such securities for Section16 or any other purposes.

2. Fully vested.

3. Options for the purchase of 9,857 shares of Common Stock were held directly by Dr. Kantesaria and assigned to Devon Park Associates, L.P. immediately upon exercise.

Remarks:

	/s/ Dale Ritter, Attorney-in-Fact	07/16/2015
	/s/ Dale Ritter, Attorney-in-Fact	07/16/2015
	/s/ Dale Ritter, Attorney-in-Fact	07/16/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.